The response of the benign hypertrophied prostate to endocrine therapy
Publisher
Springer Netherlands
Reference82 articles.
1. Abrams, P. M., Shah, P. J. R., Stone, R. and Choa, R. G. (1982). Bladder outflow obstruction treated with phenoxybenzamine. Br. J. Urol. (In Press) 2. Argyrou, F., Blandy, J. P., Gow, J. G., Singh, M., Tresidder, G. C. and Vinnicombe, J. (1974). The price of prostatectomy. Br. Med. J., 2, 511 3. Asano, M., Kanzaki, S., Sekiguchi, E. and Tasaka, T. (1971). Inhibition of prostatic growth in rabbits with anti-ovine prolactin serum. J. Urol., 106, 248 4. Aubrey, D. A. and Khosla, T. (1971). The effect of 17a-hydroxy-19-nor progesterone caproate (SH582) on benign prostatic hypertrophy. Br. J. Surg., 58, 648 5. Auf, G. and Ghanadian, R. (1982). Characterisation and measurement of cytoplasmic and nuclear oestradiol-l7ß receptor proteins in benign hypertrophied human prostate. J. Endocrinol., 93, 305
|
|